Jeff Johnson
Stock Analyst at Robert W. Baird
(4.48)
# 1,046
Out of 4,386 analysts
608
Total ratings
49.6%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintained: Buy | $98 → $85 | $66.79 | +27.26% | 55 | Jun 5, 2026 | |
| ENOV Enovis | Maintained: Buy | $45 → $37 | $23.68 | +56.25% | 15 | May 8, 2026 | |
| PODD Insulet | Maintained: Buy | $360 → $248 | $151.51 | +63.69% | 45 | May 7, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 75.75 → CHF 71.76 | $53.26 | +34.74% | 33 | May 7, 2026 | |
| INMD InMode | Maintained: Hold | $17 → $14 | $13.50 | +3.70% | 38 | May 7, 2026 | |
| NVST Envista Holdings | Maintained: Buy | $30 → $31 | $23.44 | +32.25% | 37 | May 7, 2026 | |
| HSIC Henry Schein | Maintained: Buy | $104 → $97 | $78.05 | +24.28% | 56 | May 6, 2026 | |
| DXCM DexCom | Maintained: Buy | $87 → $80 | $76.62 | +4.41% | 60 | May 1, 2026 | |
| SYK Stryker | Maintained: Buy | $437 → $385 | $301.53 | +27.68% | 37 | May 1, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $100 → $92 | $87.27 | +5.42% | 37 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $14 | $10.26 | +36.45% | 53 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 → $14 | $13.87 | +0.94% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $205 → $218 | $172.05 | +26.71% | 66 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $18 → $30 | $18.47 | +62.43% | 60 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $48.70 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $7.32 | n/a | 1 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $49 | - | n/a | 6 | Dec 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $100.01 | n/a | 1 | Apr 11, 2016 |
The Cooper Companies
Jun 5, 2026
Maintained: Buy
Price Target: $98 → $85
Current: $66.79
Upside: +27.26%
Enovis
May 8, 2026
Maintained: Buy
Price Target: $45 → $37
Current: $23.68
Upside: +56.25%
Insulet
May 7, 2026
Maintained: Buy
Price Target: $360 → $248
Current: $151.51
Upside: +63.69%
Alcon Inc.
May 7, 2026
Maintained: Buy
Price Target: CHF 75.75 → CHF 71.76
Current: $53.26
Upside: +34.74%
InMode
May 7, 2026
Maintained: Hold
Price Target: $17 → $14
Current: $13.50
Upside: +3.70%
Envista Holdings
May 7, 2026
Maintained: Buy
Price Target: $30 → $31
Current: $23.44
Upside: +32.25%
Henry Schein
May 6, 2026
Maintained: Buy
Price Target: $104 → $97
Current: $78.05
Upside: +24.28%
DexCom
May 1, 2026
Maintained: Buy
Price Target: $87 → $80
Current: $76.62
Upside: +4.41%
Stryker
May 1, 2026
Maintained: Buy
Price Target: $437 → $385
Current: $301.53
Upside: +27.68%
Zimmer Biomet Holdings
Apr 29, 2026
Maintained: Hold
Price Target: $100 → $92
Current: $87.27
Upside: +5.42%
Feb 27, 2026
Maintained: Hold
Price Target: $12 → $14
Current: $10.26
Upside: +36.45%
Feb 18, 2026
Maintained: Hold
Price Target: $28 → $14
Current: $13.87
Upside: +0.94%
Feb 5, 2026
Maintained: Buy
Price Target: $205 → $218
Current: $172.05
Upside: +26.71%
Dec 16, 2025
Upgraded: Buy
Price Target: $18 → $30
Current: $18.47
Upside: +62.43%
Dec 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $48.70
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $67
Current: $7.32
Upside: n/a
Dec 4, 2017
Reiterated: Hold
Price Target: $42 → $49
Current: -
Upside: n/a
Apr 11, 2016
Reiterated: Hold
Price Target: n/a
Current: $100.01
Upside: n/a